Fig. 4From: Targeted BRD4 protein degradation by dBET1 ameliorates acute ischemic brain injury and improves functional outcomes associated with reduced neuroinflammation and oxidative stress and preservation of blood–brain barrier integritydBET1 protects against inflammatory and oxidative damage in the ischemic cortex. A Effect of dBET1 on neuroinflammation following tMCAO was examined by measuring the mRNA levels of pro-inflammatory cytokines and chemokines IL-1β, IL-6, TNF-α, Ccl2, Cxcl1, and Cxcl10 in peri-infarct regions of cortex at 48 h after tMCAO. Compared to sham controls, stroke evoked a prominent increase in the above markers, which were significantly suppressed by dBET1 treatment. n = 5 per sham group, n = 6 stroke veh group, n = 7 stroke dBET1 group. *P < 0.05, **P < 0.01, ***P < 0.001. B Representative western immunoblots showed the expression levels of 4-HNE-modified proteins and NADPH oxidase isoform NOX2 (GP91phox), two oxidative stress markers, and SOD2 and GPX1, two antioxidant proteins, in the ischemic cortex at 48 h after tMCAO and sham controls. β-actin was used as a loading control. C Quantitative analysis in B showed that stroke led to a significant increase in 4 HNE and GP91phox and a decline in SOD2 and GPX1, which were reduced by dBET1. n = 5 per sham group, n = 6 per stroke group. *P < 0.05, **P < 0.01, ***P < 0.001Back to article page